August 27, 2025 a 07:43 am
MRK: Fundamental Ratio Analysis - Merck & Co., Inc.
Merck & Co., Inc. operates as a healthcare company worldwide with strong historical roots dating back to 1891. The company boasts a diversified portfolio across pharmaceutical and animal health sectors. While its fundamentals show room for improvement, analysts maintain a positive outlook with a consensus rating of 'Buy'.
Fundamental Rating
Merck's fundamentals reveal mixed scores across various financial metrics, suggesting potential areas for improvement in terms of equity returns and debt management.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 5 | |
| Return On Equity | 1 | |
| Return On Assets | 1 | |
| Debt To Equity | 1 | |
| Price To Earnings | 2 | |
| Price To Book | 1 |
Historical Rating
The historical ratings reflect fluctuations in Merck's performance, with recent scores remaining consistent across multiple evaluation periods.
| Date | Overall | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-08-26 | 2 | 5 | 1 | 1 | 1 | 2 | 1 |
| Previous Period | 0 | 5 | 1 | 1 | 1 | 2 | 1 |
Analyst Price Targets
Analysts have set varied price targets, with the consensus aligning to a target of $90, midway between the high and low estimates.
| High | Low | Median | Consensus |
|---|---|---|---|
| $98 | $82 | $90 | $90 |
Analyst Sentiment
Market sentiment suggests a strong inclination towards 'Buy', underscoring Merck's credible position in the healthcare industry.
| Recommendation | Number of Ratings | Distribution |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 25 | |
| Hold | 9 | |
| Sell | 1 | |
| Strong Sell | 0 |
Conclusion
Overall, Merck & Co., Inc. presents a solid investment case with its diverse operations in pharmaceuticals and animal health. While fundamental metrics indicate potential challenges, particularly in returns and leverage, the company's strategic partnerships and historical reliability favor its growth prospects. Analysts suggest a firm 'Buy' due to the potential for long-term value creation. As always, investors should weigh these insights against individual risk tolerances and market conditions.